Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity

被引:16
作者
Lima, Soraia Lopes [1 ]
Rossato, Luana [1 ]
de Azevedo Melo, Analy Salles [1 ]
机构
[1] Univ Fed Sao Paulo, Special Lab Mycol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Candida haemulonii complex; Candida auris biofilm production; Caenorhabditis elegans pathogenicity; ANTIFUNGAL SUSCEPTIBILITY; DRUG-RESISTANCE; FUNGEMIA; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; NOV;
D O I
10.1016/j.micpath.2020.104461
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida haemulonii species complex (Can. haemulonii sensu stricto, Can. duobushaemulonii and Can. haemulonii var. vulnera) and related species (Can. auris and Can. pseudohaemulonii) have attracted attention due to reduced susceptibility to azoles and amphotericin B. Furthermore, attributes of potential virulence have been recognized in Can. haemulonii species complex and Can. auris, like the capability to form biofilm, which represent the most important risk factors for persistent candidemia. However, the relationship between biofilm production and impact on host mortality is still unclear. To evaluate the potential virulence of Can. haemulonii species complex and Can. auris isolates by correlating biofilm production and capacity to kill Caenorhabditis elegans as an in vivo model. In this study, virulence factors were characterized among a total of sixty-six Can. haemulonii species complex and Can. auris isolates to gain insight about virulence traits of these pathogenic yeasts by evaluating the in vitro biofilm production and potential pathogenicity for Cae. elegans, as an in vivo infection model. All clinical isolates tested were biofilm producer, interand intra-specific differences on the biofilm forming capacity by the strains were observed. Can. auris and Can. haemuolonii var. vulnera showed similar biofilm production, both higher than Can. haemulonii sensu stricto and Can. duobushaemulonii. Regarding the virulence of the Cae. elegans model, Can. haemulonii species complex and Can. auris isolates were capable of causing infection in Cae. elegans, and our data suggest that the high biofilm production by Can. haemulonii var. vulnera and Can. duobushaemulonii isolates may impact in the pathogenicity caused on Cae. elegans.
引用
收藏
页数:6
相关论文
共 44 条
[1]   Multidrug-Resistant Candida haemulonii and C-auris, Tel Aviv, Israel [J].
Ben-Ami, Ronen ;
Berman, Judith ;
Novikov, Ana ;
Bash, Edna ;
Shachor-Meyouhas, Yael ;
Zakin, Shin ;
Maor, Yasmin ;
Tarabia, Jalal ;
Schechner, Vered ;
Adler, Amos ;
Finn, Talya .
EMERGING INFECTIOUS DISEASES, 2017, 23 (02) :195-203
[2]   First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia [J].
Calvo, Belinda ;
Melo, Analy S. A. ;
Perozo-Mena, Armindo ;
Hernandez, Martin ;
Francisco, Elaine Cristina ;
Hagen, Ferry ;
Meis, Jacques F. ;
Colombo, Arnaldo Lopes .
JOURNAL OF INFECTION, 2016, 73 (04) :369-374
[3]   Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts [J].
Cendejas-Bueno, E. ;
Kolecka, A. ;
Alastruey-Izquierdo, A. ;
Theelen, B. ;
Groenewald, M. ;
Kostrzewa, M. ;
Cuenca-Estrella, M. ;
Gomez-Lopez, A. ;
Boekhout, T. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) :3641-3651
[4]   Multidrug-resistant endemic clonal strain of Candida auris in India [J].
Chowdhary, A. ;
Kumar, V. Anil ;
Sharma, C. ;
Prakash, A. ;
Agarwal, K. ;
Babu, R. ;
Dinesh, K. R. ;
Karim, S. ;
Singh, S. K. ;
Hagen, F. ;
Meis, J. F. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (06) :919-926
[5]   Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally [J].
Chowdhary, Anuradha ;
Sharma, Cheshta ;
Meis, Jacques F. .
PLOS PATHOGENS, 2017, 13 (05)
[6]   Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer [J].
Colombo, A. L. ;
de Almeida Junior, J. N. ;
Slavin, Monica A. ;
Chen, Sharon C-A ;
Sorrell, Tania C. .
LANCET INFECTIOUS DISEASES, 2017, 17 (11) :E344-E356
[7]  
Colombo AL, 2017, CURR OPIN INFECT DIS, V30, P528, DOI [10.1097/QCO.0000000000000411, 10.1097/qco.0000000000000411]
[8]  
Cotter G, 2000, BRIT J BIOMED SCI, V57, P241
[9]   Candida haemulonii Complex Species, Brazil, January 2010-March 2015 [J].
de Almeida, Joao Nobrega, Jr. ;
Pontes Lima Assy, Joao Guilherme ;
Levin, Anna S. ;
Del Negro, Gilda M. B. ;
Giudice, Mauro C. ;
Tringoni, Marcela Pullice ;
Thomaz, Danilo Yamamoto ;
Motta, Adriana Lopes ;
Abdala, Edson ;
Pierroti, Ligia Camara ;
Strabelli, Tania ;
Munhoz, Ana Lucia ;
Rossi, Flavia ;
Benard, Gil .
EMERGING INFECTIOUS DISEASES, 2016, 22 (03) :561-563
[10]   Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model [J].
Fakhim, Hamed ;
Vaezi, Afsane ;
Dannaoui, Eric ;
Chowdhary, Anuradha ;
Nasiry, Davood ;
Faeli, Leila ;
Meis, Jacques F. ;
Badali, Hamid .
MYCOSES, 2018, 61 (06) :377-382